Incyte Corporation
INCY
$86.92
$0.760.88%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 4.58B | 4.41B | 4.24B | 4.08B | 3.86B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 4.58B | 4.41B | 4.24B | 4.08B | 3.86B |
| Cost of Revenue | 2.06B | 2.70B | 2.67B | 2.67B | 2.45B |
| Gross Profit | 2.52B | 1.72B | 1.57B | 1.40B | 1.41B |
| SG&A Expenses | 1.29B | 1.24B | 1.22B | 1.19B | 1.15B |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3.59B | 4.17B | 4.13B | 4.06B | 3.79B |
| Operating Income | 997.97M | 241.22M | 115.95M | 20.21M | 65.04M |
| Income Before Tax | 1.26B | 314.66M | 316.63M | 273.86M | 351.14M |
| Income Tax Expenses | 391.58M | 293.39M | 284.02M | 241.38M | 253.84M |
| Earnings from Continuing Operations | 870.87 | 21.27 | 32.62 | 32.48 | 97.30 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 870.87M | 21.27M | 32.62M | 32.48M | 97.30M |
| EBIT | 997.97M | 241.22M | 115.95M | 20.21M | 65.04M |
| EBITDA | 1.09B | 334.78M | 209.10M | 111.99M | 155.69M |
| EPS Basic | 4.50 | 0.37 | 0.31 | 0.17 | 0.38 |
| Normalized Basic EPS | 3.56 | 1.32 | 0.90 | 0.57 | 0.67 |
| EPS Diluted | 4.40 | 0.32 | 0.27 | 0.14 | 0.36 |
| Normalized Diluted EPS | 3.49 | 1.27 | 0.87 | 0.55 | 0.65 |
| Average Basic Shares Outstanding | 773.49M | 797.67M | 828.44M | 859.51M | 890.96M |
| Average Diluted Shares Outstanding | 790.20M | 809.63M | 838.66M | 867.36M | 897.69M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |